Tales from the crypt[ic] sites of the extracellular matrix

Trends in Cell Biology

Volumn 13, Issue 7, 2003, Pages 366-375

  Schenk, Susann ^a   Quaranta, Vito ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CATHEPSIN L; COLLAGEN DERIVATIVE; COLLAGEN TYPE 15; COLLAGEN TYPE 18; COLLAGEN TYPE 4; ENDOSTATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITOPE; FIBRONECTIN; GELATINASE A; LAMININ 1; MATRIX METALLOPROTEINASE 14; NEU DIFFERENTIATION FACTOR; OSTEONECTIN; PLASMA PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CELL MIGRATION; CELL MOTILITY; CONFORMATIONAL TRANSITION; DEVELOPMENTAL STAGE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MACROMOLECULE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

EID: 0038771156     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(03)00129-6     Document Type: Review

References (66)

1. Davis G.E., et al. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am. J. Pathol. 156:2000;1489-1498.
2. Geiger B., et al. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat. Rev. Mol. Cell Biol. 2:2001;793-805.
3. Hornebeck W., et al. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin. Cancer Biol. 12:2002;231-241.
4. Marneros A.G., Olsen B.R. The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol. 20:2001;337-345.
5. Sasaki T., et al. Structure and function of collagen-derived endostatin inhibitors of angiogenesis. IUBMB Life. 53:2002;77-84.
6. Xu J., et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J. Cell Biol. 154:2001;1069-1079.
7. Hangai M., et al. Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis. Am. J. Pathol. 161:2002;1429-1437.
8. Hohenester E., Engel J. Domain structure and organisation in extracellular matrix proteins. Matrix Biol. 21:2002;115-128.
9. Erickson H.P. Reversible unfolding of fibronectin type III and immunoglobulin domains provides the structural basis for stretch and elasticity of titin and fibronectin. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10114-10118.
10. Zhong C., et al. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol. 141:1998;539-551.
11. Litvinovich S.V., et al. Reversible unfolding of an isolated heparin and DNA binding fragment, the first type III module from fibronectin. Biochim. Biophys. Acta. 1119:1992;57-62.
12. 1 module localizes to lipid rafts and stimulates cell growth and contractility. J. Cell Biol. 158:2002;175-184.
13. Langenbach K.J., Sottile J. Identification of protein-disulfide isomerase activity in fibronectin. J. Biol. Chem. 274:1999;7032-7038.
14. 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C. Biochemistry. 37:1998;5464-5474.
15. O'Reilly M.S., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285.
16. Dhanabal M., et al. Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274:1999;11721-11726.
17. Yamaguchi N., et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18:1999;4414-4423.
18. Hohenester E., et al. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J. 17:1998;1656-1664.
19. Ramchandran R., et al. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem. Biophys. Res. Commun. 255:1999;735-739.
20. Sasaki T., et al. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18:1999;6240-6248.
21. Sasaki T., et al. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J. Mol. Biol. 301:2000;1179-1190.
22. Stetefeld J., et al. Crystal structure of three consecutive laminin-type epidermal growth factor-like (LE) modules of laminin gamma1 chain harboring the nidogen binding site. J. Mol. Biol. 257:1996;644-657.
23. Mayer U., et al. A single EGF-like motif of laminin is responsible for high affinity nidogen binding. EMBO J. 12:1993;1879-1885.
24. Schenk S., et al. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J. Cell Biol. 161:2003;197-209.
25. 1 chain in solution. J. Mol. Biol. 257:1996;658-668.
26. Sander C., Schneider R. Database of homology-derived protein structures and the structural meaning of sequence alignment. Proteins. 9:1991;56-68.
27. Mayer U., et al. Low nidogen affinity of laminin-5 can be attributed to two serine residues in EGF-like motif γ2III4. FEBS Lett. 365:1995;129-132.
28. Engel J., et al. Domain organizations of extracellular matrix proteins and their evolution. Development. 1:1994;35-42.
29. Swindle C.S., et al. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor. J. Cell Biol. 154:2001;459-468.
30. Panayotou G., et al. Domains of laminin with growth-factor activity. Cell. 56:1989;93-101.
31. Engel J. EGF-like domains in extracellular matrix proteins: localized signals for growth and differentiation? FEBS Lett. 251:1989;1-7.
32. Giannelli G., et al. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science. 277:1997;225-228.
33. Koshikawa N., et al. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148:2000;615-624.
34. 2 chain. J. Biol. Chem. 275:2000;22728-22735.
35. Veitch D.P., et al. Mammalian Tolloid metalloproteinase, and not matrix metalloprotease 2 nor membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J. Biol. Chem. 278:2002;15661-15668.
36. 2 chain degradation to mammary epithelial cell migration. J. Cell Sci. 114:2001;2967-2976.
37. 2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion. Cancer Res. 63:2003;222-229.
38. Giannelli G., et al. Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids. Am. J. Pathol. 154:1999;1193-1201.
39. Koch M., et al. A novel member of the netrin family, β-netrin, shares homology with the β chain of laminin: identification, expression, and functional characterization. J. Cell Biol. 151:2000;221-234.
40. Serafini T., et al. The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell. 78:1994;409-424.
41. Kennedy T.E., et al. Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord. Cell. 78:1994;425-435.
42. MacLennan A.J., et al. Immunohistochemical localization of netrin-1 in the embryonic chick nervous system. J. Neurosci. 17:1997;5466-5479.
43. Hedgecock E.M., et al. The unc-5, unc-6, and unc-40 genes guide circumferential migrations of pioneer axons and mesodermal cells on the epidermis in C. elegans. Neuron. 4:1990;61-85.
44. Colorado P.C., et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 60:2000;2520-2526.
45. Fairbrother W.J., et al. Backbone dynamics of the EGF-like domain of heregulin-α J. Mol. Biol. 279:1998;1149-1161.
46. Metin C., et al. A role for netrin-1 in the guidance of cortical efferents. Development. 124:1997;5063-5074.
47. Ebendal T. Use of collagen gels to bioassay nerve growth factor activity. Rush R.A. Nerve Growth Factors. 1989;81-93 John Wiley and Sons.
48. Alcantara S., et al. Netrin 1 acts as an attractive or as a repulsive cue for distinct migrating neurons during the development of the cerebellar system. Development. 127:2000;1359-1372.
49. Jones F.S., Jones P.L. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev. Dyn. 218:2000;235-259.
50. Ohashi T., et al. Dynamics and elasticity of the fibronectin matrix in living cell culture visualized by fibronectin-green fluorescent protein. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2153-2158.
51. Sasaki T., et al. Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. EMBO J. 17:1998;1625-1634.
52. Kamphaus G.D., et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J. Biol. Chem. 275:2000;1209-1215.
53. Maeshima Y., et al. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J. Biol. Chem. 275:2000;21340-21348.
54. Maeshima Y., et al. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science. 295:2002;140-143.
55. Faisal Khan K.M., et al. Exposure of cryptic domains in the α1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression. J. Biol. Chem. 277:2002;13778-13786.
56. Hershkoviz R., et al. Tumour necrosis factor-α interacts with laminin and functions as a pro-adhesive cytokine. Immunology. 85:1995;125-130.
57. Ardini E., et al. Identification of a novel function for 67-kDa laminin receptor: increase in laminin degradation rate and release of motility fragments. Cancer Res. 62:2002;1321-1325.
58. Fukai F., et al. Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases. Biochemistry. 34:1995;11453-11459.
59. Yasuda T., Poole A.R. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthritis Rheum. 46:2002;138-148.
60. Watanabe K., et al. Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin. Biochemistry. 39:2000;7138-7144.
61. Grant M.B., et al. Fibronectin fragments modulate human retinal capillary cell proliferation and migration. Diabetes. 47:1998;1335-1340.
62. Werb Z., et al. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109:1989;877-889.
63. Brekken R.A., Sage E.H. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19:2001;816-827.
64. Levicar N., et al. Lysosomal enzymes, cathepsins in brain tumour invasion. J. Neurooncol. 58:2002;21-32.
65. Kos J., Lah T.T. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer. Oncol. Rep. 5:1998;1349-1361.
66. Cooper J.B. Aspartic proteinases in disease: a structural perspective. Curr. Drug Targets. 3:2002;155-173.